Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Weight loss was accompanied by improvements in cardiometabolic risk factors, particularly for those with prediabetes
Supplied as a lyophilised powder
Do not inject into a muscle (intramuscularly) or vein (intravenously)
Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an fc fusion protein
Individual tolerability, insurance coverage, and physician expertise also factor into the decision there is no universal answer
US$ 28.70
US$ 29.86
US$ 20.29
US$ 26.70
